Incomplete HCT (Hematopoietic Cell Transplantation) Clinical Trial
A Phase I Open-label Dose-escalation Study to Evaluate the Safety of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation
This study aims to evaluate the safety of intramuscular (IM) administration of PLX-R18 in subjects with incomplete hematopoietic recovery following HCT.
|Status||Active, not recruiting|
|Start date||February 8, 2017|
|Completion date||October 2021|